Literature DB >> 11219426

Screening the molecular surface of human anticoagulant protein C: a search for interaction sites.

B O Villoutreix1, D G Covell, A M Blom, A Wallqvist, U Friedrich, B Dahlbäck.   

Abstract

Protein C (PC), a 62 kDa multi-modular zymogen, is activated to an anticoagulant serine protease (activated PC or APC) by thrombin bound to thrombomodulin on the surface of endothelial cells. PC/APC interacts with many proteins and the characterisation of these interactions is not trivial. However, molecular modelling methods help to study these complex biological processes and provide basis for rational experimental design and interpretation of the results. PC/APC consists of a Gla domain followed by two EGF modules and a serine protease domain. In this report, we present two structural models for full-length APC and two equivalent models for full-length PC, based on the X-ray structures of Gla-domainless APC and of known serine protease zymogens. The overall elongated shape of the models is further cross-validated using size exclusion chromatography which allows evaluation of the Stokes radius (rs for PC = 33.15 A; rs for APC = 34.19 A), frictional ratio and axial ratio. We then propose potential binding sites at the surface of PC/APC using surface hydrophobicity as a determinant of the preferred sites of intermolecular recognition. Most of the predicted binding sites are consistent with previously reported experimental data, while some clusters highlight new regions that should be involved in protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219426     DOI: 10.1023/a:1011158717139

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  62 in total

1.  Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.

Authors:  E Thorelli; R J Kaufman; B Dahlbäck
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

2.  Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.

Authors:  K E Knobe; A Berntsdotter; L Shen; J Morser; B Dahlbäck; B O Villoutreix
Journal:  Proteins       Date:  1999-05-01

3.  Structural characterization of inter-alpha-inhibitor. Evidence for an extended shape.

Authors:  A M Blom; M Mörgelin; M Oyen; J Jarvet; E Fries
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

4.  The kinetics of protein-protein recognition.

Authors:  J Janin
Journal:  Proteins       Date:  1997-06

5.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

6.  Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.

Authors:  L Shen; B Dahlbäck; B O Villoutreix
Journal:  Biochemistry       Date:  2000-03-21       Impact factor: 3.162

7.  The location of the active site of blood coagulation factor VIIa above the membrane surface and its reorientation upon association with tissue factor. A fluorescence energy transfer study.

Authors:  C D McCallum; R C Hapak; P F Neuenschwander; J H Morrissey; A E Johnson
Journal:  J Biol Chem       Date:  1996-11-08       Impact factor: 5.157

8.  Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.

Authors:  B O Villoutreix; B Dahlbäck
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

9.  The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study.

Authors:  V P Mutucumarana; E J Duffy; P Lollar; A E Johnson
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

Review 10.  Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.

Authors:  B Dahlbäck
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

View more
  5 in total

1.  Structure-based method for analyzing protein-protein interfaces.

Authors:  Ying Gao; Renxiao Wang; Luhua Lai
Journal:  J Mol Model       Date:  2003-11-22       Impact factor: 1.810

2.  Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.

Authors:  Changming Chen; Likui Yang; Bruno O Villoutreix; Xuefeng Wang; Qiulan Ding; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2017-04-13       Impact factor: 5.249

3.  Inhibition of thrombin formation by active site mutated (S360A) activated protein C.

Authors:  Gerry A F Nicolaes; Paul E Bock; Kenneth Segers; Karin C A A Wildhagen; Björn Dahlbäck; Jan Rosing
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

4.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

5.  Zymogen and activated protein C have similar structural architecture.

Authors:  Bosko M Stojanovski; Leslie A Pelc; Xiaobing Zuo; Enrico Di Cera
Journal:  J Biol Chem       Date:  2020-08-27       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.